BioAmber (BIOA) Tops Q3 EPS by 14c

BioAmber (NYSE: BIOA) reported Q3 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Light & Wonder to report Q2 results Aug. 4, reaffirms FY26 outlook
• Gold Royalty acquires two Nevada royalties for $0.8 million